Speakers

A John Camm, Ajay Kakkar, Howard Liebman, Alexander Turpie, Freek W. A. Verheugt, Jeffrey Weitz

A John Camm, MD, QHP, MD, FRCP, FACC, FESC

Professor, Clinical Cardiology
St. George’s University of London
Consultant Cardiologist
St. George’s Hospital
London, United Kingdom

Professor Camm's research interests include clinical electrocardiology, clinical cardiac electrophysiology, cardiac arrhythmias, implantable devices for rhythm control, risk stratification for sudden death in patients with ischemic heart disease, for thromboembolism in patients with atrial fibrillation, and for ventricular arrhythmia in patients with cardiomyopathy and channelopathy, adverse cardiovascular events in new and old drugs, and anticoagulation.

Professor Camm holds the European Society of Cardiology Gold Medal. He is President of the European Heart Rhythm Association, a board member of the World Society of Arrhythmias, and a trustee of the Drug Safety Research Unit. He is president of the Arrhythmia Alliance, and founder and trustee of the Atrial Fibrillation Association.

He is editor-in-chief of Clinical Cardiology and EHJ-Case Reports and an editor of the European Heart Journal and the European Society of Cardiology Textbook of Cardiovascular Medicine.

Back to top

Ajay Kakkar, BSc, MBBS, PhD, FRCS

Professor of Surgery
University College London
Chairman of University College London Partners Academic Health Science Partnership
Director of the Thrombosis Research Institute
London, United Kingdom

Rt Hon Professor the Lord Kakkar completed his medical degree at King’s College London and received a PhD from Imperial College London. His research interests include the prevention and treatment of venous and arterial thromboembolic disease and cancer-associated thrombosis.

Lord Kakkar was created a life peer in 2010 and sits on the cross benches of the House of Lords. He is Chairman of the House of Lords Appointments Commission and UK Business Ambassador for Healthcare and Life Sciences. Lord Kakkar was appointed a member of Her Majesty’s Most Honourable Privy Council in December 2014 and is Chairman of the Judicial Appointments Commission.

Back to top

Howard Liebman, MD

Professor, Medicine
Don Feinstein Chair, Hematology
Keck School of Medicine of USC
Los Angeles, California

Since 1999, Dr. Liebman has authored or co-authored over 100 medical articles and chapters and has led well over a hundred lectures across the United States, South America, Europe, and Japan on a variety of medical topics.

He has also been the recipient of millions of dollars in research grants, reviewed a number of medical journals, and is a former Chair of the Massachusetts Governor’s Task Force subcommittee on experimental therapies and clinical trials for AIDS.

In addition to his academic responsibilities, Dr. Liebman is an attending staff member of the LAC+USC Medical Center, the USC/Norris Comprehensive Cancer Center and the Keck Hospital of USC.

Dr. Liebman is on the forefront of research in thrombotic and hemorrhagic disorders. His lab is currently studying the genetic risk factors responsible for thrombotic diseases including venous thrombosis, pulmonary embolism, arterial thrombosis, and thrombosis associated with cancer chemotherapy. Additional studies are elucidating the role of prothrombotic defects in developing osteonecrosis. He has also been the principle investigator on a number of clinical trials in the management of immune thrombocytopenia. His research group has made important discoveries on the role of infectious agents in the development of immune thrombocytopenia. Dr. Liebman is also internationally known for his work in the relationships between venous thrombotic disease and underlying malignancy and has served on the Cancer and Thrombosis Guideline Committee of the American Society of Clinical Oncology.

Back to top

Alexander Turpie, MB, FRCP, FACP, FACC, FRCPC

Emeritus Professor, Medicine
McMaster University
Internist
Hamilton Health Sciences
Hamilton, Ontario, Canada

Dr. Tuprie received his medical education from the University of Glasgow, Scotland, was a clinical research fellow at Glasgow Royal Infirmary and Stobhill General Hospital, and lectured at the University of East Africa Medical School, Nairobi, Kenya.

Professor Turpie’s research interests include new antithrombotic drugs for the management of venous and arterial thrombosis, and anticoagulant therapy in patients with prosthetic heart valves.

He has served on numerous committees and is a frequent lecturer at professional meetings worldwide. Professor Turpie has authored more than 700 articles, abstracts, book chapters, and books, and he has been a reviewer for many international journals, in addition to serving on the editorial boards of Vascular Medicine and Heart Drug.

Back to top

Freek W. A. Verheugt, MD, FACC, FAHA, FESC

Professor, Cardiology
Heart-Lung Centre of the University Medical Centre of Nijmegen
Chair, Cardiology
Onze Lieve Vrouwe Gasthuis
Amsterdam, The Netherlands

Dr. Verheught attended medical school at the University Leiden and University of Amsterdam. He earned an MD from the University of Amsterdam. He completed military service at the Central Laboratory of The Netherlands Red Cross Blood Transfusion Service in Amsterdam and a thesis at the University of Amsterdam entitled, "Neutrophil granulocyte antigens and antibodies."

Dr. Verheugt completed an Internal Medicine residency at the University Hospital Wilhelmina Gasthuis in Amsterdam, followed by a fellowship in Cardiology at the University Hospital Dijkzigt, Erasmus University, Rotterdam.

His main interests are pharmacological and interventional treatments of acute coronary syndromes and atrial fibrillation.

Professor Verheugt has published more than 400 papers in peer-reviewed international journals and has more than 14,000 citations. He is an editorial board member of European Heart Journal and an editorial adviser to Lancet, New England Journal of Medicine, and Circulation.

Back to top

Jeffrey Weitz, MD, FRCP(C), FACP

Professor of Medicine & Biochemistry
McMaster University
Executive Director, Thrombosis & Atherosclerosis Research Institute Hamilton, Ontario, Canada

Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Weitz focuses his clinical work in the area of thrombosis. He directs a well-funded research laboratory that focuses on the biochemistry of blood coagulation and fibrinolysis as it applies to venous and arterial thrombosis. Dr Weitz holds an Endowed Chair in Cardiovascular Research and the Canada Research Chair (Tier 1) in Thrombosis.

Dr. Weitz is a Fellow of the American Heart Association, the American and European Colleges of Cardiology, the Society of Vascular Medicine, the American College of Chest Physicians, the Canadian Academy of Health Sciences, the European Union Academy of Sciences, and the Royal Society of Canada. He is a member of the Executive Council of the International Society on Thrombosis and Haemostasis.

Dr. Weitz has published over 450 peer-reviewed papers and 55 textbook chapters. He has received numerous awards for his research and academic achievements and has delivered several prestigious named lectures.

Back to top